Product Information
HYDROCODONE ER 30 MG CAPSULE is a generic product labeled by Alvogen Inc., priced at $7.2115 per EA under NDC 47781041260. Its NADAC has been published 92 times since Apr 17, 2024.
FDA first approved this application on Jan 21, 2020.
Strength
30 mg/1
Manufacturer
Alvogen Inc.NDC
47781041260
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
1/22/2025
Active Ingredients
HYDROCODONE BITARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA206986FDA Approved
1/21/2020
On Market Since
1/21/2020
Pharmacological Classes
Price Statistics
The NADAC for HYDROCODONE ER 30 MG CAPSULE has been published 92 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.2115 per EA |
|---|---|
| All-time high | $7.2646 (Nov 13, 2024) |
| All-time low | $6.9577 (Aug 21, 2024) |
| 52-week high | $7.2115 |
| 52-week low | $7.2115 |
| Median price | $7.2115 |
| Average price | $7.1709 |
| Largest weekly change | +4.4% (Oct 23, 2024) |
| Weeks tracked | 92 |
| Tracking since | Apr 17, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
0.0%
3Y
N/A
5Y
N/A
All
+1.5%
Last surveyed Jan 14, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Hydrocodone Bitartrate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alvogen Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Hydrocodone Bitartrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDROCODONE ER 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for HYDROCODONE ER 30 MG CAPSULE, manufactured by Alvogen Inc., is $7.2115 per EA (NDC 47781041260), effective Jan 14, 2026.
How has the price of HYDROCODONE ER 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for HYDROCODONE ER 30 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 92 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for HYDROCODONE ER 30 MG CAPSULE?
Since Apr 17, 2024, the NADAC for HYDROCODONE ER 30 MG CAPSULE has ranged from a low of $6.9577 (Aug 21, 2024) to a high of $7.2646 (Nov 13, 2024), with a median of $7.2115 per EA.
Are there cheaper alternatives to HYDROCODONE ER 30 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of HYDROCODONE ER 30 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures HYDROCODONE ER 30 MG CAPSULE?
HYDROCODONE ER 30 MG CAPSULE (NDC 47781041260) is labeled by Alvogen Inc., and CMS classifies it as a generic product.